Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Fluarix vs Fluzone in Children
NCT00764790Phase 3Completed
- Sponsor
- GSK
- Start
- Oct 2008
- Primary completion
- Mar 2009
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 5
01
Overview
A Phase 3 trial of Fluarix in influenza, sponsored by GSK. Started Oct 2008; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00764790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764790.